151 related articles for article (PubMed ID: 22768978)
1. Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry.
Ye G; Zhu B; Yao Z; Yin P; Lu X; Kong H; Fan F; Jiao B; Xu G
J Proteome Res; 2012 Aug; 11(8):4361-72. PubMed ID: 22768978
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
[TBL] [Abstract][Full Text] [Related]
3. Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis.
Li ZF; Wang J; Huang C; Zhang S; Yang J; Jiang A; Zhou R; Pan D
Rapid Commun Mass Spectrom; 2010 Sep; 24(18):2765-75. PubMed ID: 20814984
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling study of early and late recurrence of hepatocellular carcinoma based on liquid chromatography-mass spectrometry.
Zhou L; Liao Y; Yin P; Zeng Z; Li J; Lu X; Zheng L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():163-70. PubMed ID: 24582150
[TBL] [Abstract][Full Text] [Related]
5. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
6. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
[TBL] [Abstract][Full Text] [Related]
7. Urinary metabonomics study in a rat model in response to protein-energy malnutrition by using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry.
Wu Z; Li M; Zhao C; Zhou J; Chang Y; Li X; Gao P; Lu X; Li Y; Xu G
Mol Biosyst; 2010 Nov; 6(11):2157-63. PubMed ID: 20717558
[TBL] [Abstract][Full Text] [Related]
8. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
[TBL] [Abstract][Full Text] [Related]
9. Analysis of survival in very early hepatocellular carcinoma after resection.
Lee JI; Lee JW; Kim YS; Choi YA; Jeon YS; Cho SG
J Clin Gastroenterol; 2011 Apr; 45(4):366-71. PubMed ID: 20962671
[TBL] [Abstract][Full Text] [Related]
10. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
[TBL] [Abstract][Full Text] [Related]
11. Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery.
Yokoo H; Kondo T; Okano T; Nakanishi K; Sakamoto M; Kosuge T; Todo S; Hirohashi S
Cancer Sci; 2007 May; 98(5):665-73. PubMed ID: 17391314
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of early hepatocellular carcinoma after hepatic resection.
Maeda T; Shimada M; Harimoto N; Tsujita E; Aishima S; Tanaka S; Shirabe K; Maehara Y
Hepatogastroenterology; 2008; 55(85):1428-32. PubMed ID: 18795705
[TBL] [Abstract][Full Text] [Related]
13. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
[TBL] [Abstract][Full Text] [Related]
14. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry.
Xue R; Lin Z; Deng C; Dong L; Liu T; Wang J; Shen X
Rapid Commun Mass Spectrom; 2008 Oct; 22(19):3061-8. PubMed ID: 18767022
[TBL] [Abstract][Full Text] [Related]
15. High HBV-DNA titer in surrounding liver rather than in hepatocellular carcinoma tissue predisposes to recurrence after curative surgical resection.
Choi JG; Chung YH; Kim JA; Jin YJ; Park WH; Lee D; Shim JH; Lee YS; Seo DD; Jang MK; Kim KM; Lim YS; Lee HC; Lee YS; Yu E; Lee YJ
J Clin Gastroenterol; 2012; 46(5):413-9. PubMed ID: 22105184
[TBL] [Abstract][Full Text] [Related]
16. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
[TBL] [Abstract][Full Text] [Related]
17. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
[TBL] [Abstract][Full Text] [Related]
18. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.
Covey AM; Maluccio MA; Schubert J; BenPorat L; Brody LA; Sofocleous CT; Getrajdman GI; Fong Y; Brown KT
Cancer; 2006 May; 106(10):2181-9. PubMed ID: 16596622
[TBL] [Abstract][Full Text] [Related]
19. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
Tanaka S; Mogushi K; Yasen M; Noguchi N; Kudo A; Kurokawa T; Nakamura N; Inazawa J; Tanaka H; Arii S
J Am Coll Surg; 2009 Mar; 208(3):368-74. PubMed ID: 19317998
[TBL] [Abstract][Full Text] [Related]
20. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation.
Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K
Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
